Q15427 (SF3B4_HUMAN) Homo sapiens (Human)

Splicing factor 3B subunit 4 UniProtKBInterProSTRINGInteractive Modelling

424 aa; Sequence (Fasta) ; 22 identical sequences

Available Structures

33 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
The cryo-EM structure of the human 17S U2 snRNP Heteromer
O43719; O75533; P08579; P09661; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15393; Q15428; Q15459; Q7L014; Q7RTV0; Q9BWJ5;
11-181
100.09B0;ZN;
The cryo-EM structure of human pre-17S U2 snRNP Heteromer
O43719; O75533; P08579; P09661; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15393; Q15428; Q15459; Q7RTV0; Q86XP3; Q9BWJ5;
11-181
100.09B0;ZN;
human 17S U2 snRNP low resolution part Heteromer
O43719; O75533; P08579; P09661; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15428; Q15459; Q7L014; Q9Y3B4;
11-181
100.0
human 17S U2 snRNP Heteromer
O43719; O75533; P08579; P09661; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15393; Q15428; Q15459; Q7L014; Q7RTV0; Q9BWJ5; Q9Y3B4;
11-181
100.0
The cryo-EM structure of the human pre-A complex Heteromer
O75533; O75937; P08579; P08621; P09012; P09234; P09661; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15393; Q15428; Q15459; Q15637; Q7L014; Q7RTV0; Q9BWJ5;
11-181
100.0ZN;SJT;
The cryo-EM structure of human Bact-III complex Heteromer
O15541; O43660; O60231; O60306; O60508; O75533; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8WUA2; Q96DI7; Q99459; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y3C6;
13-180
100.0IHP;GTP;MG;ZN;
The cryo-EM structure of human post-Bact complex Heteromer
O43660; O60231; O60306; O60508; O75533; O75934; O95926; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q13435; Q13573; Q15029; Q15393; Q6P2Q9; Q7RTV0; Q8WUA2; Q96DI7; Q99459; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y3C6;
13-180
100.0IHP;GTP;MG;ZN;
The cryo-EM structure of human Bact-II complex Heteromer
O15541; O43660; O60231; O60306; O75533; O75643; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8WUA2; Q96DI7; Q99459; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UNP9; Q9UQ35; Q9Y3C6;
13-180
100.0IHP;GTP;MG;ZN;
The cryo-EM structure of human Bact-IV complex Heteromer
O15541; O43660; O60231; O60306; O60508; O75533; O75934; O95926; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q13573; Q15029; Q15393; Q6P2Q9; Q7RTV0; Q8WUA2; Q96DI7; Q99459; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y3C6;
13-180
100.0IHP;GTP;MG;ZN;
The cryo-EM structure of human pre-Bact complex Heteromer
O43660; O60306; O60870; O75533; O75643; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8IYB3; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCS7; Q9NW64; Q9P013; Q9UNP9; Q9Y388; Q9Y3B4;
13-180
100.0GTP;MG;ZN;
The cryo-EM structure of human Bact-I complex Heteromer
O15541; O43660; O60231; O60306; O75533; O75643; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15428; Q15459; Q6P2Q9; Q6UX04; Q7RTV0; Q8IYB3; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UNP9; Q9UQ35; Q9Y388; Q9Y3B4;
13-180
100.0IHP;GTP;MG;ZN;
Cryo-EM structure of the cross-exon pre-B+5'ss+ATPgammaS complex Heteromer
O43172; O43290; O43395; O43447; O75533; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q15029; Q15393; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WWY3; Q96DI7; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
12-89
100
Structure of a late-stage activated spliceosome (BAqr) arrested with a dominant-negative Aquarius m… Heteromer
O15541; O43660; O60231; O60306; O60508; O75533; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8WUA2; Q92917; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9ULR0; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y3C6;
12-89
10012×ZN;IHP;GTP;MG;
Cryo-EM structure of human exon-defined spliceosome in the late pre-B state. Heteromer
O43172; O43290; O43395; O75533; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q13523; Q15029; Q15393; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WVK2; Q8WWY3; Q96DI7; Q9BTD8; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
12-89
100IHP;MG;GTP;ZN;
Cryo-EM structure of the cross-exon pre-B+5'ss complex Heteromer
O43172; O43290; O43395; O75533; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q13523; Q15029; Q15393; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WVK2; Q8WWY3; Q96DI7; Q9BTD8; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
12-89
100
Human pre-Bact-1 spliceosome Heteromer
O14776; O43660; O75533; O75643; O95777; P08579; P09661; P14678; P41223; P52298; P55081; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; Q07955; Q09161; Q12874; Q13435; Q13573; Q15029; Q15393; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8IYB3; Q8NAV1; Q8TAD8; Q96DI7; Q96NC0; Q99459; Q9BWJ5; Q9BZL1; Q9NW64; Q9P013; Q9UK45; Q9Y2W2; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
12-89
100IHP;GTP;MG;GTG;
Cryo-EM structure of the cross-exon pre-B+ATP complex Heteromer
O43172; O43290; O43395; O43447; O75533; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q15029; Q15393; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WWY3; Q96DI7; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
12-89
100
Cryo-EM structure of the cross-exon pre-B+5'ssLNG+ATPyS complex Heteromer
O43172; O43290; O43395; O43447; O75533; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q15029; Q15393; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WWY3; Q96DI7; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
12-89
100
Cryo-EM Structure of the Activated Human Minor Spliceosome (minor Bact Complex) Heteromer
O15541; O43660; O60231; O75533; O75643; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q13356; Q13435; Q13573; Q15029; Q15393; Q5RL73; Q6P2Q9; Q6UX04; Q7RTV0; Q8IYB3; Q8TAD8; Q92917; Q96DI7; Q99459; Q9BRD0; Q9BWG6; Q9BWJ5; Q9BZJ0; Q9H6L4; Q9HCG8; Q9P013; Q9P021; Q9UQ35; Q9Y388; Q9Y3B4;
12-89
100IHP;GTP;MG;K;G5J;ZN;
Cryo-EM Structure of the human minor pre-B complex (pre-precatalytic spliceosome) U12 snRNP part Heteromer
O75533; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q13435; Q15393; Q7RTV0; Q9BWG6; Q9BWJ5; Q9Y3B4;
12-89
100ZN;
Structural organization of a late activated human spliceosome (Baqr, core region) Heteromer
O15541; O43660; O60231; O75533; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15428; Q6P2Q9; Q7RTV0; Q8WUA2; Q92917; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9NW64; Q9P013; Q9UQ35; Q9Y3C6;
12-89
10012×ZN;IHP;GTP;MG;
Cryo-EM structure of the cross-exon pre-B complex Heteromer
O43172; O43290; O43395; O75533; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q13523; Q15029; Q15393; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WVK2; Q8WWY3; Q96DI7; Q9BTD8; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
12-89
100
Cryo-EM structure of human exon-defined spliceosome in the early B state. Heteromer
O43172; O43290; O43395; O43447; O75533; O75554; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q15029; Q15393; Q15428; Q15459; Q2TAY7; Q6P2Q9; Q7RTV0; Q8WWY3; Q96DI7; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
12-89
100IHP;GTP;MG;ZN;
Cryo-EM structure of human exon-defined spliceosome in the mature pre-B state. Heteromer
O43172; O43290; O43395; O75533; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q13523; Q15029; Q15393; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WVK2; Q8WWY3; Q96DI7; Q9BTD8; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
12-89
100IHP;MG;GTP;ZN;
Human pre-Bact-2 spliceosome (SF3b/U2 snRNP portion) Heteromer
O60870; O75533; Q12874; Q13435; Q15393; Q15428; Q7RTV0; Q8IYB3; Q8TAD8; Q99459; Q9BWJ5; Q9Y388; Q9Y3B4;
12-89
100
Human pre-Bact-2 spliceosome Heteromer
O43660; O60306; O60508; O60870; O75533; O75643; P08579; P09661; P14678; P41223; P55081; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13356; Q13435; Q13573; Q15029; Q15393; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8IYB3; Q8NAV1; Q8TAD8; Q8WYA6; Q96DI7; Q96NC0; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9BZL1; Q9HCS7; Q9NW64; Q9P013; Q9UNP9; Q9Y388; Q9Y3B4;
12-89
100GTP;MG;IHP;
Cryo-EM structure of a human activated spliceosome (early Bact) at 4.9 angstrom. Heteromer
O15541; O43660; O60231; O75533; O75643; P08579; P09661; P14678; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q13573; Q15029; Q15393; Q15428; Q15459; Q6P2Q9; Q6UX04; Q7RTV0; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9P013; Q9Y388; Q9Y3B4;
12-89
100IHP;GTP;MG;ZN;
cryo-EM structure of a human activated spliceosome (mature Bact) at 5.1 angstrom. Heteromer
O15541; O43660; O60231; O60306; O60508; O75533; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15029; Q15393; Q15428; Q15459; Q6P2Q9; Q6UX04; Q7RTV0; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y388; Q9Y3B4; Q9Y3C6;
12-89
100IHP;GTP;MG; 13×ZN;
The Cryo-EM Structure of the Precusor of Human Pre-catalytic Spliceosome (pre-B complex) Heteromer
O43172; O43395; O75533; O75643; O94906; O95777; P08579; P09661; P14678; P55769; P62304; P62306; P62308; P62310; P62312; P62314; P62316; P62318; P83876; Q12874; Q13435; Q15029; Q15393; Q15428; Q15459; Q53GS9; Q6P2Q9; Q7RTV0; Q8WWY3; Q96DI7; Q9BUQ8; Q9BWJ5; Q9UK45; Q9Y333; Q9Y3B4; Q9Y4Y9; Q9Y4Z0;
12-89
100IHP;GTP;MG;
Cryo-EM structure of the human activated spliceosome (late Bact) at 6.5 angstrom Heteromer
O43660; O60231; O60306; O60508; O75533; O75643; O75934; P08579; P09661; P14678; P41223; P62304; P62306; P62308; P62314; P62316; P62318; Q12874; Q13435; Q15029; Q15393; Q15428; Q15459; Q6P2Q9; Q7RTV0; Q8TAD8; Q96DI7; Q99459; Q9BRD0; Q9BWJ5; Q9BZJ0; Q9HCG8; Q9HCS7; Q9NW64; Q9P013; Q9UMS4; Q9UNP9; Q9UQ35; Q9Y388; Q9Y3B4; Q9Y3C6;
12-89
100IHP;ALA;GTP;MG; 10×ZN;
Structure of the U2 5' module of the A3'-SSA complex Heteromer
O75533; Q12874; Q13435; Q15393; Q15428; Q7RTV0; Q9BWJ5;
12-88
100.0SJT;ZN;
Solution structure of the first RRM domain of human spliceosomal protein SF3b49monomer2-96
96.84
Solution structure of the second RRM domain in splicing factor = 3Bmonomer102-184
100

6 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8hk1.1.Emonomer0.7011-181
100.00
8i0p.1.9monomer0.6913-180
100.00
1u1r.1.Bmonomer0.647-182
24.86
4yoe.1.Amonomer0.5494-216
21.49
5kw6.1.Bmonomer0.5389-217
21.88
4pkd.1.Bmonomer0.5197-217
23.08